Neu (C-erbB-2) Oncogene in Breast Cancer and its Possible Association with the Risk of Distant Metastases a Retrospective Study and Review of Literature

Authors

  • A. Ph. Makar From the Department of Gynecology, Obstetrics, ST Augustinus and ST Camillus University Hospitals, Antwerp, and the Department of Pathology, University of Ghent, Ghent, Belgium
  • E. J. Desmedt From the Department of Gynecology, Obstetrics, ST Augustinus and ST Camillus University Hospitals, Antwerp, and the Department of Pathology, University of Ghent, Ghent, Belgium
  • C. R. De Potter From the Department of Gynecology, Obstetrics, ST Augustinus and ST Camillus University Hospitals, Antwerp, and the Department of Pathology, University of Ghent, Ghent, Belgium
  • J. S. Vanderheyden From the Department of Gynecology, Obstetrics, ST Augustinus and ST Camillus University Hospitals, Antwerp, and the Department of Pathology, University of Ghent, Ghent, Belgium
  • E. A. Schatteman From the Department of Gynecology, Obstetrics, ST Augustinus and ST Camillus University Hospitals, Antwerp, and the Department of Pathology, University of Ghent, Ghent, Belgium

DOI:

https://doi.org/10.3109/02841869009096392

Keywords:

Breast cancer, neu oncogene, metastasis

Abstract

By immunohistochemical staining C-erbB-2 (neu) oncogene was found on the cell membrane in 19 out of 44 primary breast cancers from a pathology archive. No obvious relation was found between neu oncogene, age, and lymph node status and tumor size. There was a tendency towards smaller primary tumors and more estrogen receptor-negative tumors in the oncogene-positive group. No case of distant metastasis during follow-up was found among the oncogene-negative patients, while 6 oncogene-positive patients developed such metastases. This suggests that the neu oncongene is an independant prognostic factor, which might predict the development of distant metastasis. Further studies including more patients and long-term survival analysis are, however, needed in order to evaluate the prognostic significance of the neu oncogene.

Downloads

Download data is not yet available.

Downloads

Published

1990-01-01

How to Cite

Makar, A. P., Desmedt, E. J., De Potter, C. R., Vanderheyden, J. S., & Schatteman, E. A. (1990). Neu (C-erbB-2) Oncogene in Breast Cancer and its Possible Association with the Risk of Distant Metastases a Retrospective Study and Review of Literature. Acta Oncologica, 29(7), 931–934. https://doi.org/10.3109/02841869009096392